NCT00469456 - Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease | Biotech Hunter

Enrollment

265

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Alzheimer's Disease

Interventions

DRUG

Memantine

Memantine 20mg (10mg twice daily) oral administration for 12 weeks

DRUG

placebo

Placebo oral administration twice daily for 12 weeks

Trial Locations (25)

2031

Forest Investigative Site, Randwick

2052

Forest Investigative Site, Johannesburg

2077

Forest Investigative Site, Hornsby

2217

Forest Investigative Site, Kogarah

2250

Forest Investigative Site, East Gosford

2300

Forest Investigative Site, Newcastle

3081

Forest Investigative Site, Heidelberg West

3101

Forest Investigative Site, Kew

3182

Forest Investigative Site, Box Hill

3199

Forest Investigative Site, Frankston

4001

Forest Investigative Site, Johannesburg

Forest Investigative Site, Durban

4032

Forest Investigative Site, Chermside

4350

Forest Investigative Site, Toowoomba

5000

Forest Investigative Site, Adelaide

5011

Forest Investigative Site, Woodville

6001

Forest Investigative Site, Perth

6014

Forest Investigative Site, Port Elizabeth

6529

Forest Investigative Site, George

7500

Forest Investigative Site, Cape Town

7530

Forest Investigative Site, Cape Town

8022

Forest Investigative Site, Christchurch

Forest Investigative Site, Timaru

0622

Forest Investigative Site, North Shore

0182

Forest Investigative Site, Pretoria